Basic and preclinical research services

LIMR offers research services to research and affiliated faculty, incubating companies, and physicians throughout Main Line Health. Here, you will find information about various services.

Learn more about Basic and Preclinical Research Services

Center for Human Antibody Technology

The Center for Human Antibody Technology (CHAT) is a core facility that uses a powerful human antibody cloning platform technology developed by LIMR’s Scott Dessain, MD, PhD.

Learn more about the Center for Human Antibody Technology

LIMR Chemical Genomics Center

The mission of LIMR Chemical Genomics Center (LCGC) is to advance medicinal discovery. We provide proprietary, uniquely diverse, drug-like chemical libraries and other resources that measurably improve the efficiency of high throughput screening (HTS) by 500 percent, and potentially reveal unexpected drug synergies that may otherwise not be discovered.

Learn more about the LIMR Chemical Genomics Center

Biotechnology company incubator

Technology development at LIMR focuses on three main functions, including promoting the development and commercialization of discoveries through technology transfer, identifying new early-stage biotech companies and partnering with organizations in our community to increase awareness of LIMR and bring additional resources to our facility.

Learn more about our Biotechnology Company Incubator

Assessment of drug candidates’ cardiac QT liability

Before new drug candidates can be tested in humans, it is critical to assess whether they will provoke an irregular heart rhythm. Gan-Xin Yan, MD, PhD, has pioneered a method called "wedge prep" that uses slices of heart tissue from the adult ventricle of a rabbit to deliver quick, accurate testing.


Office of Research Protections

The mission of the Office of Research Protections (ORP) is to forge a partnership with the Main Line Health research community to conduct safe and ethical research.

Learn more about the Office of Research Protections (ORP)